Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Man Broker Ratings



Broker Ratings for Man (EMG)


Share Price: 202.20Bid: 202.10Ask: 202.20Change: 0.00 (0.00%)No Movement on Man Group
Spread: 0.10Spread as %: 0.05%Open: 204.10High: 204.10Low: 199.80Yesterday’s Close: 202.20


Broker Recommendations for Man (EMG)
DateBrokerRatingOld TargetNew TargetChange
13-Oct-17Credit SuisseOutperform195.00195.00Reiteration
13-Oct-17Shore CapitalBuy--Reiteration
13-Oct-17numisHold155.00155.00Reiteration
28-Sep-17RBC Capital Marketssector perform-175.00Downgrade
12-Sep-17Credit SuisseOutperform-195.00Reiteration
02-Aug-17CitigroupNeutral-170.00Downgrade
02-Aug-17Goldman SachsBuy-175.00Reiteration
11-Jul-17JefferiesHold169.00164.00Downgrade
06-Jul-17JP Morgan CazenoveOverweight175.00180.00Reiteration
20-Apr-17Numis SecuritiesHold-135.00Reiteration
10-Apr-17JefferiesBuy167.00169.00Reiteration
06-Mar-17Goldman SachsBuy-167.00Reiteration
02-Mar-17CitigroupBuy-160.00Reiteration
01-Mar-17Credit SuisseOutperform195.00195.00Reiteration
22-Feb-17Exane BNP ParibasNeutral-140.00Reiteration


Registered members see more Man broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.